​Maryland Prescription Drug Monitoring Program

Click here​ for updates on the Dispenser migration from RxSentry to RxGov, beginning April 2019. 

HEALTHCARE PROVIDER REGISTRATION: Please click on the PDMP logo button below for access to the CRISP Registration Page​

PDMP logo.jpg​​ 

 Maryland PDMP



The Prescription Drug Monitoring Program (PDMP) has been established by the Maryland Department of Health, to support healthcare providers and their patients in the safe and effective use of prescription drugs. The PDMP collects and securely stores information on drugs that contain controlled substances and are dispensed to patients in Maryland. Drug dispensers, including pharmacies and healthcare practitioners, electronically report the information that is stored in the PDMP database.
Access to prescription data is made available at no-cost to physicians, nurse practitioners, pharmacists and others that provide pharmaceutical care to their patients.  By law, healthcare providers may only access information on patients under their care. Use of prescription information improves providers’ ability to manage the benefits and risks of controlled substance medications and identify potentially harmful drug interactions.
The PDMP also assists agencies responsible for ensuring public health and safety through the investigation of illegal or inappropriate prescribing, dispensing or use of prescription drugs. Investigators must register with the PDMP and may only request data to support an existing investigation, typically supported by a subpoena for the information.
Lastly, the PDMP supports research and educational initiatives designed to broaden public understanding of prescription drug abuse and develop more effective approaches to addressing this serious personal and public health challenge.
The PDMP is a core component of the State’s and many local jurisdictions’ strategies for reducing alcohol- and drug-related overdoses. 

For general information about the PDMP, see the Frequently Asked Questions​ section.For information about clinical user access to PDMP data, please view the PDMP Training Video​ .If you have additional questions, please contact the PDMP​.